OTCMKTS:REPR - Repro-Med Systems Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.32 -0.07 (-5.04 %)
(As of 05/24/2018 01:28 PM ET)
Previous Close$1.39
Today's Range$1.32 - $1.3950
52-Week Range$0.34 - $1.50
Volume21,134 shs
Average Volume15,646 shs
Market Capitalization$52.84 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.68

About Repro-Med Systems (OTCMKTS:REPR)

Repro Med Systems, Inc. designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system. The company sells its products directly to physician offices, hospitals, and other institutional customers, as well as through regional distributors specializing in the hospital respiratory care market. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York.

Receive REPR News and Ratings via Email

Sign-up to receive the latest news and ratings for REPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:REPR
CUSIPN/A
Phone845-469-2042

Debt

Debt-to-Equity RatioN/A
Current Ratio6.65
Quick Ratio5.17

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.24 million
Price / Sales4.16
Cash Flow$0.0061 per share
Price / Cash215.48
Book Value$0.21 per share
Price / Book6.29

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins2.90%
Return on Equity7.97%
Return on Assets6.70%

Miscellaneous

Employees69
Outstanding Shares38,570,000

Repro-Med Systems (OTCMKTS:REPR) Frequently Asked Questions

What is Repro-Med Systems' stock symbol?

Repro-Med Systems trades on the OTCMKTS under the ticker symbol "REPR."

Who are some of Repro-Med Systems' key competitors?

Who are Repro-Med Systems' key executives?

Repro-Med Systems' management team includes the folowing people:
  • Mr. Andrew I. Sealfon, Co-Founder, Chairman, CEO, Pres and Head of R&D (Age 72)
  • Ms. Karen Fisher, Chief Financial Officer, Treasurer and Corp. Sec. (Age 52)
  • Dr. Fred L. Ma M.D., Ph.D., Chief Medical Officer
  • Mr. Steven Kamphausen, Global VP of Sales & Marketing

Has Repro-Med Systems been receiving favorable news coverage?

News articles about REPR stock have trended somewhat positive on Thursday, Accern reports. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Repro-Med Systems earned a coverage optimism score of 0.15 on Accern's scale. They also assigned news stories about the company an impact score of 46.05 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Repro-Med Systems?

Shares of REPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Repro-Med Systems' stock price today?

One share of REPR stock can currently be purchased for approximately $1.32.

How big of a company is Repro-Med Systems?

Repro-Med Systems has a market capitalization of $52.84 million and generates $12.24 million in revenue each year. Repro-Med Systems employs 69 workers across the globe.

How can I contact Repro-Med Systems?

Repro-Med Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The company can be reached via phone at 845-469-2042 or via email at [email protected]


MarketBeat Community Rating for Repro-Med Systems (REPR)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  33 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  75
MarketBeat's community ratings are surveys of what our community members think about Repro-Med Systems and other stocks. Vote "Outperform" if you believe REPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REPR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Repro-Med Systems (OTCMKTS:REPR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/24/2016 forward)

Earnings

Repro-Med Systems (OTCMKTS:REPR) Earnings History and Estimates Chart

Earnings by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Repro-Med Systems (OTCMKTS REPR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/27/2016Q4 2016$0.01$3.19 millionViewN/AView Earnings Details
5/18/2016Q1 2016$0.01$3.31 millionViewN/AView Earnings Details
10/2/2015Q3 2015$0.01$3.17 millionViewN/AView Earnings Details
5/8/2015Q1 2015$0.01$3.45 millionViewN/AView Earnings Details
10/15/2014Q3 2014$0.01$2.51 millionViewN/AView Earnings Details
5/29/2014Q1 2014$0.01$2.64 millionViewN/AView Earnings Details
5/29/2013Q1 2013$0.01$2.00 millionViewN/AView Earnings Details
10/15/2012Q3 2012$0.01ViewN/AView Earnings Details
5/29/2012Q1 2012$0.01ViewN/AView Earnings Details
1/17/2012Q4 2011$0.01ViewN/AView Earnings Details
7/15/2011Q2 2011$0.01ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Repro-Med Systems (OTCMKTS:REPR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Repro-Med Systems (OTCMKTS REPR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 48.00%
Insider Trading History for Repro-Med Systems (OTCMKTS:REPR)

Repro-Med Systems (OTCMKTS REPR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2018Joseph M Jr. MankoDirectorBuy24,274$1.40$33,983.60View SEC Filing  
3/16/2018Joseph M Jr. MankoDirectorBuy63,110$1.29$81,411.90View SEC Filing  
3/1/2018Joseph M Jr. MankoDirectorBuy35,000$1.36$47,600.00View SEC Filing  
2/27/2018Joseph M Jr. MankoDirectorBuy58,000$1.33$77,140.00View SEC Filing  
2/22/2018Joseph M Jr. MankoDirectorBuy109,300$1.30$142,090.00View SEC Filing  
12/15/2017Joseph M Jr. MankoDirectorBuy396,692$0.89$353,055.88View SEC Filing  
12/12/2017Joseph M Jr. MankoDirectorBuy137,225$0.90$123,502.50View SEC Filing  
12/6/2017Joseph M Jr. MankoDirectorBuy50,811$0.84$42,681.24View SEC Filing  
11/30/2017Joseph M Jr. MankoDirectorBuy77,600$0.82$63,632.00View SEC Filing  
11/28/2017Joseph M Jr. MankoDirectorBuy222,710$0.80$178,168.00View SEC Filing  
11/10/2017Joseph M Jr. MankoDirectorBuy128,175$0.66$84,595.50View SEC Filing  
9/15/2017Joseph M Jr. MankoDirectorBuy146,418$0.50$73,209.00View SEC Filing  
5/30/2017Joseph M Jr. MankoDirectorBuy7,353$0.40$2,941.20View SEC Filing  
2/13/2017Joseph M Jr. MankoDirectorBuy30,000$0.40$12,000.00View SEC Filing  
2/2/2017Joseph M Jr. MankoDirectorBuy40,000$0.41$16,400.00View SEC Filing  
1/27/2017Joseph M Jr. MankoDirectorBuy7,700$0.43$3,311.00View SEC Filing  
1/25/2017Joseph M Jr. MankoDirectorBuy15,000$0.41$6,150.00View SEC Filing  
1/23/2017Joseph M Jr. MankoDirectorBuy45,000$0.42$18,900.00View SEC Filing  
1/17/2017Joseph M Jr. MankoDirectorBuy5,000$0.42$2,100.00View SEC Filing  
1/9/2017Joseph M Jr. MankoDirectorBuy22,500$0.43$9,675.00View SEC Filing  
1/3/2017Joseph M Jr. MankoDirectorBuy321,821$0.47$151,255.87View SEC Filing  
11/9/2016Joseph M Jr. MankoDirectorBuy9,700$0.41$3,977.00View SEC Filing  
11/4/2016Joseph M Jr. MankoDirectorBuy30,000$0.41$12,300.00View SEC Filing  
10/31/2016Joseph M Jr. MankoDirectorBuy25,400$0.44$11,176.00View SEC Filing  
10/18/2016Joseph M Jr. MankoDirectorBuy9,000$0.41$3,690.00View SEC Filing  
10/14/2016Joseph M Jr. MankoDirectorBuy10,100$0.43$4,343.00View SEC Filing  
10/11/2016Joseph M Jr. MankoDirectorBuy10,000$0.42$4,200.00View SEC Filing  
10/10/2016Joseph M Jr. MankoDirectorBuy32,500$0.43$13,975.00View SEC Filing  
10/3/2016Joseph M Jr. MankoDirectorBuy10,000$0.43$4,300.00View SEC Filing  
9/30/2016Joseph M Jr. MankoDirectorBuy136,248$0.44$59,949.12View SEC Filing  
8/15/2016Joseph M Jr. MankoDirectorBuy30,000$0.44$13,200.00View SEC Filing  
8/11/2016Joseph M Jr. MankoDirectorBuy20,000$0.44$8,800.00View SEC Filing  
8/1/2016Joseph M Jr. MankoDirectorBuy29,000$0.45$13,050.00View SEC Filing  
7/28/2016Joseph M Jr. MankoDirectorBuy20,000$0.43$8,600.00View SEC Filing  
7/26/2016Joseph M Jr. MankoDirectorBuy61,300$0.43$26,359.00View SEC Filing  
7/21/2016Joseph M Jr. MankoDirectorBuy18,800$0.44$8,272.00View SEC Filing  
7/12/2016Joseph M Jr. MankoDirectorBuy10,000$0.44$4,400.00View SEC Filing  
7/7/2016Joseph M Jr. MankoDirectorBuy10,000$0.44$4,400.00View SEC Filing  
7/6/2016Joseph M Jr. MankoDirectorBuy30,000$0.44$13,200.00View SEC Filing  
4/11/2016Joseph M Jr. MankoMajor ShareholderBuy15,000$0.31$4,650.00View SEC Filing  
2/16/2016Joseph M Jr. MankoMajor ShareholderBuy21,900$0.45$9,855.00View SEC Filing  
2/1/2016Joseph M Jr. MankoMajor ShareholderBuy28,800$0.45$12,960.00View SEC Filing  
1/28/2016Joseph M Jr. MankoMajor ShareholderBuy37,345$0.41$15,311.45View SEC Filing  
1/26/2016Joseph M Jr. MankoMajor ShareholderBuy34,500$0.42$14,490.00View SEC Filing  
1/22/2016Joseph M Jr. MankoMajor ShareholderBuy44,934$0.41$18,422.94View SEC Filing  
4/16/2013Remo SpagnoliDirectorBuy10,000$0.22$2,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Repro-Med Systems (OTCMKTS REPR) News Headlines

Source:
DateHeadline
Repro Med Systems to Present at the 8th Annual LD Micro Invitational ConferenceRepro Med Systems to Present at the 8th Annual LD Micro Invitational Conference
finance.yahoo.com - May 23 at 10:01 AM
Joseph M. Jr. Manko Acquires 24,274 Shares of Repro-Med Systems (REPR) StockJoseph M. Jr. Manko Acquires 24,274 Shares of Repro-Med Systems (REPR) Stock
www.americanbankingnews.com - May 11 at 8:38 PM
RMS Medical Products Victory as U.S. Federal Circuit Court of Appeals Invalidates EMED Technologies Corp.s Patent, Nullifying Infringement ClaimRMS Medical Products Victory as U.S. Federal Circuit Court of Appeals Invalidates EMED Technologies Corp.'s Patent, Nullifying Infringement Claim
finance.yahoo.com - April 10 at 10:50 AM
Joseph M. Jr. Manko Acquires 63,110 Shares of Repro-Med Systems, Inc. (REPR) StockJoseph M. Jr. Manko Acquires 63,110 Shares of Repro-Med Systems, Inc. (REPR) Stock
www.americanbankingnews.com - March 16 at 8:32 PM
Daniel Goldberger Nominated for Election to RMS Board of DirectorsDaniel Goldberger Nominated for Election to RMS Board of Directors
finance.yahoo.com - March 14 at 12:10 PM
Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 35,000 SharesRepro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 35,000 Shares
www.americanbankingnews.com - March 2 at 9:32 PM
Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 58,000 SharesRepro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 58,000 Shares
www.americanbankingnews.com - February 27 at 7:16 PM
Repro-Med Systems, Inc. (REPR) Director Purchases $142,090.00 in StockRepro-Med Systems, Inc. (REPR) Director Purchases $142,090.00 in Stock
www.americanbankingnews.com - February 22 at 9:56 PM
RMS Medical Products Announces Results for Three, Ten and Twelve Months Ending December 31, 2017RMS Medical Products Announces Results for Three, Ten and Twelve Months Ending December 31, 2017
finance.yahoo.com - February 13 at 5:11 PM
Repro-Med Systems Inc.: RMS Medical Products Named to 2018 OTCQX Best 50Repro-Med Systems Inc.: RMS Medical Products Named to 2018 OTCQX Best 50
www.finanznachrichten.de - January 26 at 5:08 PM
RMS Medical Products Named to 2018 OTCQX Best 50RMS Medical Products Named to 2018 OTCQX Best 50
finance.yahoo.com - January 26 at 5:08 PM
Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 396,692 SharesRepro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Buys 396,692 Shares
www.americanbankingnews.com - December 15 at 9:22 PM
Repro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 137,225 SharesRepro-Med Systems, Inc. (REPR) Director Joseph M. Jr. Manko Acquires 137,225 Shares
www.americanbankingnews.com - December 12 at 9:08 PM
Insider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 50,811 Shares of StockInsider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 50,811 Shares of Stock
www.americanbankingnews.com - December 7 at 6:44 PM
Insider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 77,600 Shares of StockInsider Buying: Repro-Med Systems, Inc. (REPR) Director Buys 77,600 Shares of Stock
www.americanbankingnews.com - December 1 at 10:50 PM
Repro-Med Systems, Inc. (REPR) Director Buys $178,168.00 in StockRepro-Med Systems, Inc. (REPR) Director Buys $178,168.00 in Stock
www.americanbankingnews.com - November 28 at 7:52 PM
Repro-Med Systems Inc.: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational ChangesRepro-Med Systems Inc.: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes
www.finanznachrichten.de - November 23 at 8:06 AM
RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational ChangesRMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes
finance.yahoo.com - November 23 at 8:06 AM
CORRECTION: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational ChangesCORRECTION: RMS Medical Products Announces New FDA Clearance, Warning Letter Closed, and Organizational Changes
finance.yahoo.com - November 23 at 8:06 AM
RMS Medical Products Posts Strong Results for Three and Seven Months Ending September 30, 2017RMS Medical Products Posts Strong Results for Three and Seven Months Ending September 30, 2017
finance.yahoo.com - November 18 at 11:19 AM
Joseph M. Jr. Manko Buys 128,175 Shares of Repro-Med Systems Inc. (REPR) StockJoseph M. Jr. Manko Buys 128,175 Shares of Repro-Med Systems Inc. (REPR) Stock
www.americanbankingnews.com - November 13 at 6:30 PM

SEC Filings

Repro-Med Systems (OTCMKTS:REPR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Repro-Med Systems (OTCMKTS:REPR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Repro-Med Systems (OTCMKTS REPR) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.